PAVmed (PAVM) Free Cash Flow Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 55.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.39% |
| Sep 30, 2025 | 64.19% |
| Jun 30, 2025 | 62.50% |
| Mar 31, 2025 | 49.99% |
| Dec 31, 2024 | 26.10% |
| Jun 30, 2024 | -19.99% |
| Mar 31, 2024 | -12.63% |
| Dec 31, 2023 | -21.42% |
| Sep 30, 2023 | -23.88% |
| Jun 30, 2023 | -31.50% |
| Mar 31, 2023 | -62.87% |
| Dec 31, 2022 | -61.14% |
| Sep 30, 2022 | -89.73% |
| Jun 30, 2022 | -108.13% |
| Mar 31, 2022 | -49.10% |
| Dec 31, 2021 | -81.44% |
| Sep 30, 2021 | -62.80% |
| Jun 30, 2021 | -58.27% |
| Mar 31, 2021 | -61.14% |
| Dec 31, 2020 | -61.91% |
| Sep 30, 2020 | -35.05% |
| Jun 30, 2020 | -89.41% |
| Mar 31, 2020 | -27.49% |
| Dec 31, 2019 | -50.39% |
| Sep 30, 2019 | -32.61% |
| Jun 30, 2019 | -18.99% |
| Mar 31, 2019 | -93.91% |
| Dec 31, 2018 | -67.08% |
| Sep 30, 2018 | -80.43% |
| Jun 30, 2018 | -95.96% |
| Mar 31, 2018 | -236.78% |